Literature DB >> 26314424

[Effect of ADAM10 Inhibitor GI254023X on Proliferation and Apoptosis of Acute T-Lymphoblastic Leukemia Jurkat Cells In Vitro and Its Possible Mechanisms].

Sha Ma1,2, Jie Xu1, Xue Wang1,2, Qing-Yun Wu1, Jiang Cao2, Zheng-Yu Li2, Ling-Yu Zeng1,2, Chong Chen1,3, Kai-Lin Xu1,4.   

Abstract

OBJECTIVE: To investigate the effect of ADAM10 inhibitor GI254023X on the proliferation and apoptosis of acute T-lymphoblastic leukemia Jurkat cells and its mechanisms.
METHODS: Jurkat cells were treated with different concentrations of GI254023X, the proliferation-inhibition curve was assayed and plotted by CCK-8 method, the cell viability and apoptosis was detected by flow cytometry with Annexin V and 7-AAD staining, the cleavage of Notch1 protein was determined by Western blot, the transcripts of anti-apoptotic genes BCL-2, MCL-1, BCL-xl and Notch1 target gene Hes-1 were detected by real-time PCR.
RESULTS: The GI254023X obviously inhibited the proliferation of Jurkat cells in concentration-dependent manner. As compared with the control group, the apoptosis of cells increased along with increment of GI254023X concentration. Compared with control group, the expression of Cleaved Notch1 was down-regulated while the expression of Notch1 was up-regulated in a time-dependent manner after the treatment with GI254023X. The levels of MCL-1 and Hes-1 mRNA transcripts in Jurkat cells were reduced in GI254023X treated group, but did not show obvious effect on the level of BCL-2 and BCL-xl mRNA transcripts.
CONCLUSION: GI254023X can remarkably inhibit proliferation and induce apoptosis of Jurkat cells. The inhibition of Notch1 activation and the down-regulation of apoptosis-related gene MCL-1 may be involved in the process of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26314424     DOI: 10.7534/j.issn.1009-2137.2015.04.008

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  3 in total

Review 1.  The ADAMs family of proteases as targets for the treatment of cancer.

Authors:  Maeve Mullooly; Patricia M McGowan; John Crown; Michael J Duffy
Journal:  Cancer Biol Ther       Date:  2016-04-26       Impact factor: 4.742

2.  Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia.

Authors:  Panpan Feng; Dawei Chen; Xia Wang; Yanxia Li; Zhenyu Li; Boya Li; Yupeng Zhang; Wei Li; Jingru Zhang; Jingjing Ye; Baobing Zhao; Jingxin Li; Chunyan Ji
Journal:  Leukemia       Date:  2022-08-01       Impact factor: 12.883

Review 3.  Progress in research on childhood T-cell acute lymphocytic leukemia, Notch1 signaling pathway, and its inhibitors: A review.

Authors:  Zhong Fang-Fang; Yang You; Liu Wen-Jun
Journal:  Bosn J Basic Med Sci       Date:  2021-04-01       Impact factor: 3.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.